Gout and the Risk of Non-vertebral Fracture

被引:27
作者
Kim, Seoyoung C. [1 ,2 ]
Paik, Julie M. [3 ,4 ]
Liu, Jun [1 ]
Curhan, Gary C. [3 ,4 ]
Solomon, Daniel H. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA
关键词
GOUT; FRACTURE; URIC ACID; COHORT STUDY; SERUM URIC-ACID; INCIDENT OSTEOPOROTIC FRACTURES; BONE-MINERAL DENSITY; C-REACTIVE PROTEIN; POSTMENOPAUSAL WOMEN; ALLOPURINOL USE; ASSOCIATION; POPULATION; MEN; IDENTIFICATION;
D O I
10.1002/jbmr.2978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prior studies suggest an association between osteoporosis, systemic inflammation, and pro-inflammatory cytokines such as interleukin (IL)-1 and IL-6. Conflicting findings exist on the association between hyperuricemia and osteoporosis. Furthermore, it remains unknown whether gout, a common inflammatory arthritis, affects fracture risk. Using data from a US commercial health plan (2004-2013), we evaluated the risk of non-vertebral fracture (ie, forearm, wrist, hip, and pelvis) in patients with gout versus those without. Gout patients were identified with >= 2 diagnosis codes and >= 1 dispensing for a gout-related drug. Non-gout patients, identified with >= 2 visits coded for any diagnosis and >= 1 dispensing for any prescription drugs, were free of gout diagnosis and received no gout-related drugs. Hip fracture was the secondary outcome. Fractures were identified with a combination of diagnosis and procedure codes. Cox proportional hazards models compared the risk of non-vertebral fracture in gout patients versus non-gout, adjusting for more than 40 risk factors for osteoporotic fracture. Among gout patients with baseline serum uric acid (sUA) measurements available, we assessed the risk of non-vertebral fracture associated with sUA. We identified 73,202 gout and 219,606 non-gout patients, matched on age, sex, and the date of study entry. The mean age was 60 years and 82% were men. Over the mean 2-year follow-up, the incidence rate of non-vertebral fracture per 1,000 person-years was 2.92 in gout and 2.66 in non-gout. The adjusted hazard ratio (HR) was 0.98 (95% confidence interval [CI] 0.85-1.12) for non-vertebral fracture and 0.83 (95% CI 0.65-1.07) for hip fracture in gout versus non-gout. Subgroup analysis (n = 15,079) showed no association between baseline sUA and non-vertebral fracture (HR = 1.03, 95% CI 0.93-1.15), adjusted for age, sex, comorbidity score, and number of any prescription drugs. Gout was not associated with a risk of non-vertebral fracture. Among patients with gout, sUA was not associated with the risk of non-vertebral fracture. (C) 2016 American Society for Bone and Mineral Research.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 37 条
[1]   Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women [J].
Ahn, S. H. ;
Lee, S. H. ;
Kim, B. -J. ;
Lim, K. -H. ;
Bae, S. J. ;
Kim, E. H. ;
Kim, H. -K. ;
Choe, J. W. ;
Koh, J. -M. ;
Kim, G. S. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (12) :2961-2970
[2]   Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005 [J].
Annemans, L. ;
Spaepen, E. ;
Gaskin, M. ;
Bonnemaire, M. ;
Malier, V. ;
Gilbert, T. ;
Nuki, G. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) :960-966
[3]   Association between allopurinol use and hip fracture in older patients [J].
Basu, Ujani ;
Goodbrand, James ;
McMurdo, Marion E. T. ;
Donnan, Peter T. ;
McGilchrist, Mark ;
Frost, Helen ;
George, Jacob ;
Witham, Miles D. .
BONE, 2016, 84 :189-193
[4]   C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort [J].
Berglundh, S. ;
Malmgren, L. ;
Luthman, H. ;
McGuigan, F. ;
Akesson, K. .
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (02) :727-735
[5]   Pathways for Bone Loss in Inflammatory Disease [J].
Braun, Tobias ;
Schett, Georg .
CURRENT OSTEOPOROSIS REPORTS, 2012, 10 (02) :101-108
[6]  
CDC, OST SEC OST 2015
[7]   Pathogenesis of gout [J].
Choi, HK ;
Mount, DB ;
Reginato, AM .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (07) :499-516
[8]   Identification and Validation of Vertebral Compression Fractures Using Administrative Claims Data [J].
Curtis, Jeffrey R. ;
Mudano, Amy S. ;
Solomon, Daniel H. ;
Xi, Juan ;
Melton, Elkins ;
Saag, Kenneth G. .
MEDICAL CARE, 2009, 47 (01) :69-72
[9]   Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density [J].
Dalbeth, Nicola ;
Topless, Ruth ;
Flynn, Tanya ;
Cadzow, Murray ;
Bolland, Mark J. ;
Merriman, Tony R. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (06) :985-991
[10]   Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study [J].
Dennison, Elaine M. ;
Rubin, Katrine Hass ;
Schwarz, Peter ;
Harvey, Nicholas C. ;
Bone, Karen Walker ;
Cooper, Cyrus ;
Abrahamsen, Bo .
ARCHIVES OF OSTEOPOROSIS, 2015, 10 (01)